GTBPVSIPEX• 3 Months (Normalized)
GTBP vs IPEX (GT Biopharma Inc. vs Inflection Point Acquisition Corp. V)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
IPEX Performance $3.16
-69.91%
Inflection Point Acquisition Corp. V
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+69.91 pts
GTBP outperforming by 69.91 percentage points
GTBPIPEX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP IPEX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(59 dates)
| Date | GTBP Price | GTBP Gain (%) | IPEX Price | IPEX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $3.16 | -69.91% | - | |
| Sep 23, 2026 | $7.10 | +1337.25% | $9.30 | -11.44% | +1348.69% |
| Sep 21, 2026 | $7.18 | +1353.44% | $10.23 | -2.63% | +1356.07% |
| Sep 18, 2026 | $7.16 | +1349.39% | $9.82 | -6.49% | +1355.88% |
| Sep 17, 2026 | $7.49 | +1416.19% | $10.38 | -1.20% | +1417.39% |
| Sep 16, 2026 | $7.81 | +1480.97% | $9.88 | -5.91% | +1486.88% |
| Sep 15, 2026 | $9.00 | +1721.86% | $10.39 | -1.06% | +1722.92% |
| Sep 14, 2026 | $11.63 | +2254.25% | $8.58 | -18.29% | +2272.54% |
| Sep 11, 2026 | $8.61 | +1642.91% | $8.10 | -22.86% | +1665.77% |
| Sep 10, 2026 | $6.18 | +1151.01% | $8.58 | -18.29% | +1169.30% |
| Sep 09, 2026 | $5.98 | +1110.53% | $9.18 | -12.58% | +1123.11% |
| Sep 08, 2026 | $- | $8.49 | -19.15% | - | |
| Sep 04, 2026 | $0.24 | -51.21% | $7.75 | -26.20% | -25.01% |
| Sep 03, 2026 | $0.25 | -48.99% | $10.92 | +3.99% | -52.98% |
| Sep 02, 2026 | $0.28 | -42.71% | $11.00 | +4.75% | -47.46% |
Page 1 of 4